Skip to main content
Top
Published in: The journal of nutrition, health & aging 3/2019

01-03-2019

Motoric Cognitive Risk Syndrome: Prevalence and Risk of Cognitive Impairment in a Population Studied in the Mexican Health and Aging Study 2012–2015

Authors: Sara G. Aguilar-Navarro, A. J. Mimenza-Alvarado, J. E. Aguilar-Esquivel, S. G. Yeverino-Castro, T. Juárez-Cedillo, S. Mejía-Arango

Published in: The journal of nutrition, health & aging | Issue 3/2019

Login to get access

Abstract

Objectives

The aim of this study was to determine the prevalence of Motoric Cognitive Risk (MCR) syndrome, describe associated risk factors and to determine the risk of progression to cognitive impairment after three years of follow-up, in a sample of Mexican older adults.

Design

A prospective panel study of health and aging in Mexico.

Setting and participants

Baseline and follow-up information was obtained from the Mexican Health and Aging Study’s 2012 and 2015 waves. A total of 726 subjects aged 60 years or older with normal cognition at baseline were classified into 4 groups: 1) with MCR, 2) with memory complaint only, 3) with slow gait speed only and, 4) without MCR. Cox regression analysis controlling for confounder factors was performed to determine the risk of progression to cognitive impairment in the MCR group.

Measures

Data such as gait speed, functional status and cognitive performance (standardized by age and sex in Mexican population) was collected.

Results

MCR prevalence was 14.3%. When compared with non-MCR subjects, the presence of MCR was associated with older age (p<0.01), lower educational status (p=0.05), having two or more comorbidities (p<0.05) and diabetes mellitus diagnosis (p<0.05). At follow-up and after adjusting for confounders, MCR was associated with a 2.4-fold increased risk (95% CI: 1.28-4.26, p=.000) of cognitive impairment.

Conclusions

MCR syndrome increases the risk of cognitive impairment in Mexican older adults. Simple measurements such as gait evaluation in subjects with memory complaints could allow early identification of those at risk of developing cognitive impairment.
Literature
3.
go back to reference Mejía S, Miguel-Jaimes A, Villa A, Ruiz L, Gutiérrez LM. Cognitive impairment and associated factors in older adults in Mexico. Salúd Publica Mex 2007;49 suppl 4, 475-481 Mejía S, Miguel-Jaimes A, Villa A, Ruiz L, Gutiérrez LM. Cognitive impairment and associated factors in older adults in Mexico. Salúd Publica Mex 2007;49 suppl 4, 475-481
4.
go back to reference Solomon PR, Murphy CA. Should we screen for Alzheimer’s disease? A review of the evidence for and against screening Alzheimer’s disease in primary care practice. Geriatrics 2005;60:26–31PubMed Solomon PR, Murphy CA. Should we screen for Alzheimer’s disease? A review of the evidence for and against screening Alzheimer’s disease in primary care practice. Geriatrics 2005;60:26–31PubMed
5.
go back to reference Prince M, Acosta D, Ferri CP, et al. Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve:a 10/66 Dementia Research Group population-based cohort study. Lancet 2005;7;380(9836):50-8 Prince M, Acosta D, Ferri CP, et al. Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve:a 10/66 Dementia Research Group population-based cohort study. Lancet 2005;7;380(9836):50-8
6.
7.
go back to reference Doraiswamy PM, Steffens DC, Pitchumoni S, et al. Early recognition of Alzheimer’s disease:what is consensual? What is controversial? What is practical? J Clin Psychiatry 1998;59 Suppl 13:6–18 Doraiswamy PM, Steffens DC, Pitchumoni S, et al. Early recognition of Alzheimer’s disease:what is consensual? What is controversial? What is practical? J Clin Psychiatry 1998;59 Suppl 13:6–18
8.
go back to reference Verghese J, Wang C, Lipton RB, et al. Motoric cognitive risk syndrome and the risk of dementia. J Gerontol A Biol Sci Med Sci 2013;68:412–18CrossRefPubMed Verghese J, Wang C, Lipton RB, et al. Motoric cognitive risk syndrome and the risk of dementia. J Gerontol A Biol Sci Med Sci 2013;68:412–18CrossRefPubMed
9.
go back to reference Montero M, Bergman H, Phillips NA, et al. Dual-tasking and gait in people with mild cognitive impairment. The effect of working memory. BMC Geriatr 2009;9:41 Montero M, Bergman H, Phillips NA, et al. Dual-tasking and gait in people with mild cognitive impairment. The effect of working memory. BMC Geriatr 2009;9:41
10.
go back to reference Wong R, Espinoza M, Palloni A. Adultos mayores mexicanos en contexto socioeconómico amplio:salud y envejecimiento. Salud Pública Mex 2007;49:s436–s447.PubMed Wong R, Espinoza M, Palloni A. Adultos mayores mexicanos en contexto socioeconómico amplio:salud y envejecimiento. Salud Pública Mex 2007;49:s436–s447.PubMed
11.
go back to reference Wong R, Michaels A, Palloni A. Cohort Profile:The Mexican Health and Aging Study (MHAS). Int J Epidemiol 2017;1;46(2):e2 Wong R, Michaels A, Palloni A. Cohort Profile:The Mexican Health and Aging Study (MHAS). Int J Epidemiol 2017;1;46(2):e2
12.
go back to reference Wolfe N, Imai Y, Otani C, et al. Criterion validity of the cross-cultural cognitive examination in Japan. J Gerontol 1992;47:289–91CrossRef Wolfe N, Imai Y, Otani C, et al. Criterion validity of the cross-cultural cognitive examination in Japan. J Gerontol 1992;47:289–91CrossRef
13.
go back to reference Mejía S, Wong R, Michaels A. Normative and standardized data for cognitive measures in the Mexican Health and Aging Study. Salud Pública Mex 2015;57:s90–s96CrossRef Mejía S, Wong R, Michaels A. Normative and standardized data for cognitive measures in the Mexican Health and Aging Study. Salud Pública Mex 2015;57:s90–s96CrossRef
14.
go back to reference Jorms AF, Scott R, Cullen JS, et al. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol Med 1991;21(3):785–90CrossRef Jorms AF, Scott R, Cullen JS, et al. Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol Med 1991;21(3):785–90CrossRef
15.
go back to reference Pérez MU, Sánchez N, González M, et al. Sarcopenia prevalence using simple measurements and population-based cutoff values. J Lat Am Geriatr Med 2016;2(1):8–13 Pérez MU, Sánchez N, González M, et al. Sarcopenia prevalence using simple measurements and population-based cutoff values. J Lat Am Geriatr Med 2016;2(1):8–13
16.
go back to reference Lawton MP, Brody EM. Assessment of older people:self-maintaining and instrumental activities of daily living. The Gerontologist 1969;9:179–86CrossRefPubMed Lawton MP, Brody EM. Assessment of older people:self-maintaining and instrumental activities of daily living. The Gerontologist 1969;9:179–86CrossRefPubMed
17.
go back to reference Dorantes G, Ávila JA, Mejía S, et al. Factores asociados con la dependencia funcional en los adultos mayores:un análisis secundario del Estudio Nacional sobre Salud y Envejecimiento en México. Rev Panam Salud Pública 2001;22:1–11CrossRef Dorantes G, Ávila JA, Mejía S, et al. Factores asociados con la dependencia funcional en los adultos mayores:un análisis secundario del Estudio Nacional sobre Salud y Envejecimiento en México. Rev Panam Salud Pública 2001;22:1–11CrossRef
18.
go back to reference Aguilar SG, Fuente A, Ávila JA, et al. Validez y confiabilidad del cuestionario del ENASEM para la depresión en adultos mayores. Salud Pública Mex 2007;49:256–62CrossRef Aguilar SG, Fuente A, Ávila JA, et al. Validez y confiabilidad del cuestionario del ENASEM para la depresión en adultos mayores. Salud Pública Mex 2007;49:256–62CrossRef
19.
go back to reference Kumai K, Meguro K, Kasai M, et al. Neuroepidemiologic and Neurobehavioral Characteristics of Motoric Cognitive Risk Syndrome in an Old-Old Population:The Kurihara Project. Dement Geriatr Cogn Disord Extra 2016;6:176–82CrossRef Kumai K, Meguro K, Kasai M, et al. Neuroepidemiologic and Neurobehavioral Characteristics of Motoric Cognitive Risk Syndrome in an Old-Old Population:The Kurihara Project. Dement Geriatr Cogn Disord Extra 2016;6:176–82CrossRef
20.
21.
go back to reference Lord S, Galna B, Verghese J, et al. Independent domains of gait in older adults and associated motor and nonmotor attributes:validation of a factor analysis approach. J Gerontol A Biol Sci Med Sci Jul; 2013;68(7):820–7CrossRef Lord S, Galna B, Verghese J, et al. Independent domains of gait in older adults and associated motor and nonmotor attributes:validation of a factor analysis approach. J Gerontol A Biol Sci Med Sci Jul; 2013;68(7):820–7CrossRef
22.
go back to reference Callisaya ML, Blizzard L, McGinley JL, et al. Sensorimotor factors affecting gait variability in older people-a population-based study. J Gerontol A Biol Sci Med Sci Apr; 2010;65(4):386–92CrossRef Callisaya ML, Blizzard L, McGinley JL, et al. Sensorimotor factors affecting gait variability in older people-a population-based study. J Gerontol A Biol Sci Med Sci Apr; 2010;65(4):386–92CrossRef
23.
go back to reference Verghese J, Noone ML, Johnson B, et al. Picture-based memory impairment screen for dementia. J Am Geriatr Soc Nov; 2012;60(11):2116–20CrossRef Verghese J, Noone ML, Johnson B, et al. Picture-based memory impairment screen for dementia. J Am Geriatr Soc Nov; 2012;60(11):2116–20CrossRef
24.
go back to reference Goldman R, Grossman M. Update on Apraxia. Curr Neurol Neurosci Rep 2008;8(6):490–96CrossRef Goldman R, Grossman M. Update on Apraxia. Curr Neurol Neurosci Rep 2008;8(6):490–96CrossRef
25.
go back to reference Sturman DA, Moghadamm B. The Neurobiology of Adolescence:Changes in brain architecture, functional dynamics, and behavioral tendencies. Neurosci Biobehav Rev 2011;35(8):1704–12CrossRefPubMedPubMedCentral Sturman DA, Moghadamm B. The Neurobiology of Adolescence:Changes in brain architecture, functional dynamics, and behavioral tendencies. Neurosci Biobehav Rev 2011;35(8):1704–12CrossRefPubMedPubMedCentral
26.
go back to reference Meyer JS, Barron DW. Apraxia of gait:A clinico-physiological study. Brain 1960;83(2):261–84CrossRef Meyer JS, Barron DW. Apraxia of gait:A clinico-physiological study. Brain 1960;83(2):261–84CrossRef
27.
go back to reference Doi T, Verghese J, Shimada H, et al. Motoric Cognitive Risk Syndrome:Prevalence and Risk Factors in Japanese Seniors. J Am Med Dir Assoc 2015;16:1103.e21-25CrossRefPubMed Doi T, Verghese J, Shimada H, et al. Motoric Cognitive Risk Syndrome:Prevalence and Risk Factors in Japanese Seniors. J Am Med Dir Assoc 2015;16:1103.e21-25CrossRefPubMed
28.
go back to reference Gonzales JU, James CR, Yang HS, et al. Different cognitive functions discriminate gait performance in younger and older women:A pilot study. Gait Posture 2016;50:89–95CrossRefPubMed Gonzales JU, James CR, Yang HS, et al. Different cognitive functions discriminate gait performance in younger and older women:A pilot study. Gait Posture 2016;50:89–95CrossRefPubMed
29.
go back to reference Economou A, Papageorgiou S, Karageorgiou C. Working-delayed memory difference detects mild cognitive impairment without being affected by age and education. J Clin Exp Neuropsychol 2006;28:528–35CrossRefPubMed Economou A, Papageorgiou S, Karageorgiou C. Working-delayed memory difference detects mild cognitive impairment without being affected by age and education. J Clin Exp Neuropsychol 2006;28:528–35CrossRefPubMed
30.
go back to reference Albert MS, Moss MB, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc Jul; 2001;7(5):631–9CrossRef Albert MS, Moss MB, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. J Int Neuropsychol Soc Jul; 2001;7(5):631–9CrossRef
31.
go back to reference Biessels GJ, Strachan MW, Visseren FL, et al. Dementia and cognitive decline in type 2 diabetes and prediabetic stages:towards targeted interventions. Lancet Diabetes Endocrinol 2014;2:246–e255CrossRefPubMed Biessels GJ, Strachan MW, Visseren FL, et al. Dementia and cognitive decline in type 2 diabetes and prediabetic stages:towards targeted interventions. Lancet Diabetes Endocrinol 2014;2:246–e255CrossRefPubMed
32.
33.
go back to reference Hajjar I, Yang F, Sorond F, et al. A novel aging phenotype of slow gait, impaired executive function, and depressive symptoms:relationship to blood pressure and other cardiovascular risks. J Gerontol A Biol Sci Med Sci 2009;64(9):994–1001CrossRefPubMed Hajjar I, Yang F, Sorond F, et al. A novel aging phenotype of slow gait, impaired executive function, and depressive symptoms:relationship to blood pressure and other cardiovascular risks. J Gerontol A Biol Sci Med Sci 2009;64(9):994–1001CrossRefPubMed
34.
go back to reference Lampinen P, Heikkinen E. Reduced mobility and physical activity as predictors of depressive symptoms among community-dwelling older adults:an eight-year followup study. Aging Clin Exp Res 2003;15(3):205–11CrossRefPubMed Lampinen P, Heikkinen E. Reduced mobility and physical activity as predictors of depressive symptoms among community-dwelling older adults:an eight-year followup study. Aging Clin Exp Res 2003;15(3):205–11CrossRefPubMed
35.
go back to reference Kueper JK, Speechley M, Lingum NR, et al. Motor function and incident dementia:a systematic review and meta-analysis. Age Ageing 2017;46:729–38CrossRefPubMed Kueper JK, Speechley M, Lingum NR, et al. Motor function and incident dementia:a systematic review and meta-analysis. Age Ageing 2017;46:729–38CrossRefPubMed
Metadata
Title
Motoric Cognitive Risk Syndrome: Prevalence and Risk of Cognitive Impairment in a Population Studied in the Mexican Health and Aging Study 2012–2015
Authors
Sara G. Aguilar-Navarro
A. J. Mimenza-Alvarado
J. E. Aguilar-Esquivel
S. G. Yeverino-Castro
T. Juárez-Cedillo
S. Mejía-Arango
Publication date
01-03-2019
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 3/2019
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-019-1160-7

Other articles of this Issue 3/2019

The journal of nutrition, health & aging 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.